Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties.
In this issue, CEO Karin Bryder comments on the company’s ongoing share issue for a continued aggressive international expansion with Efemia, as well as the company’s progress in the beginning of 2020 including a first framework agreement in Sweden and approvements for subscription with reimbursement in Norway and the Netherlands.
To read the newsletter, and subscribe to receive upcoming issues, follow this link:
The newsletter is published in Swedish and English, with a flexible publishing frequency based on Invent Medic’s news flow. It is produced together with the company’s IR communication partner Honeybadger, http://www.honeybadger.se. Invent Medic encourages feedback and requests on topics for upcoming issues of the newsletter.